FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules (Business Wire via Yahoo! Finance)
MIAMI----Noven Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has issued an approvable letter related to the New Drug Application for Stavzor in 125mg, 250mg and 500mg strengths.

Siemens Unveils First PLM Solution for Medical Devices (eWeek)
Teamcenter 2007 integrates compliance capabilities with design and engineering functions.